DXR
- Daxor Corporation
()
Overview
Company Summary
Daxor Corporation, commonly known as DXR, is a company that operates in the field of medical devices. Specifically, Daxor specializes in the development, manufacture, and marketing of innovative medical instrumentation and biotechnology products. Their primary focus is on technologies related to blood volume analysis.
Daxor's flagship product is called the BVA-100� Blood Volume Analyzer, which is a cutting-edge diagnostic tool used for measuring and quantifying a patient's total blood volume and red blood cell volume. The BVA-100� utilizes a unique method known as blood volume analysis, which helps healthcare professionals assess a patient's blood volume status with great accuracy.
By accurately measuring blood volume, Daxor's technology can provide crucial information for various medical applications. This includes the evaluation and diagnosis of numerous conditions such as congestive heart failure, anemia, hypertension, and kidney disease. Doctors can use the data provided by the BVA-100� to make informed decisions regarding patient care and optimize treatment strategies.
Aside from its blood volume analysis technology, Daxor also conducts research and development in the field of cryobanking and cell therapy. The company has developed a proprietary technology for the cryopreservation of cells, tissues, and organs, which has potential applications in regenerative medicine and organ transplantation.
Overall, Daxor Corporation is dedicated to advancing medical technologies that aid in the accurate assessment, diagnosis, and treatment of various conditions related to blood volume and fluid balance.